Akèy › Maladi poumon › Tennessee › Nashville
Etid klinik pou Maladi poumon nan Nashville, TN
10 etid pou Maladi poumon ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Ap rekriteFaz 2
- Premier Research Center, LLC, Hendersonville · 13 mi lwen
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Ap rekriteFaz 3
- SCRI Oncology Partners, Nashville
American Lung Association (ALA) Lung Health Cohort
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Vanderbilt University Medical Center, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- Sarah Cannon Research Institue, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Ap rekriteFaz 2
- Vanderbilt University Medical Center, Nashville
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Ap rekriteFaz 3
- Clinical Trials Center of Middle Tennesee LLC, Franklin · 17 mi lwen
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Ap rekriteFaz 2
- SCRI Oncology Partners, Nashville
Cooperative Assessment of Late Effects for SCD Curative Therapies
Ap rekriteEtid obsèvasyon
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Ap rekriteFaz 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Etid Maladi poumon nan lòt vil
- Houston, TX15 etid
- Boston, MA14 etid
- Durham, NC13 etid
- New York City, NY12 etid
- Pittsburgh, PA11 etid
- Miami, FL10 etid
- Dallas, TX10 etid
- Columbus, OH10 etid
- Los Angeles, CA10 etid
- Washington, DC10 etid
- Ann Arbor, MI10 etid
- Birmingham, AL9 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.